Leptospirosis Pathophysiology: From Entry to Multi-Organ Failure

Leptospirosis, caused by pathogenic Leptospira spirochetes, follows a biphasic course driven by direct bacterial invasion and subsequent immune-mediated injury.

Phase 1: Leptospiremic (Septicemic) Phase — Days 1–7

  • Entry: Abraded skin, intact mucous membranes, conjunctiva; water/soil contaminated with reservoir host urine (rodents, livestock).
  • Dissemination: Hematogenous spread → endothelial adhesion (adhesins: LipL32, Len proteins) → tissue invasion (liver, kidney, lung, CNS, muscle).
  • Direct Effects: Endothelial injury → ↑ capillary permeability → vasculitis, hemorrhage; direct cytotoxicity.
  • Clinical: Abrupt fever, rigors, myalgia (calves/lumbar), conjunctival suffusion (pathognomonic), headache, non-productive cough.

Phase 2: Immune Phase — Week 2 Onward

  • Antibody Production: IgM (detectable day 5–7), IgG. Immune complex formation.
  • Immune-Mediated Injury: Complement activation, neutrophil infiltration, cytokine storm (TNF-α, IL-6, IL-1) → tissue damage exceeding direct bacterial effect.
  • Organ-Specific Manifestations:
    • Liver: Jaundice (bilirubin ↑↑, transaminases modestly ↑) — Weil's disease.
    • Kidney: Tubulointerstitial nephritis → AKI, proteinuria, hypokalemia, non-oliguric initially.
    • Lung: Alveolar hemorrhage (diffuse alveolar hemorrhage syndrome) — major cause of death.
    • CNS: Aseptic meningitis, encephalitis, cranial nerve palsies.
    • Heart: Myocarditis, conduction abnormalities.
  • Hemorrhagic Diathesis: Thrombocytopenia, coagulopathy, capillary leak → petechiae, GI bleed, pulmonary hemorrhage.

Severe Disease Predictors

  • Age >60, altered mental status, oliguria, pulmonary involvement, thrombocytopenia <70k, bilirubin >5 mg/dL.

Treatment

  • Early (≤Day 5): IV Penicillin G / Ceftriaxone / Doxycycline — reduces bacterial load, may abort severe phase.
  • Late (Immune Phase): Antibiotics less effective; supportive care (renal replacement, ventilation, transfusion) dominates.
  • Corticosteroids: Controversial; some evidence for severe pulmonary hemorrhage.

Early recognition in endemic/exposure settings is critical—treatment delay drives mortality.

Cardiovascular Disease - Related Articles